| Dr Evadne G Marcolini, MD | |
|
1 Medical Center Dr, Lebanon, NH 03756 | |
| (603) 650-7254 | |
| Not Available |
| Full Name | Dr Evadne G Marcolini |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 20 Years |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649351446 | NPI | - | NPPES |
| P00725397 | Other | MD | RAILROAD MEDICARE |
| 018339300 | Medicaid | MD |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dartmouth-hitchcock Clinic | 4183537509 | 1139 |
News Archive
Women with increased levels of M-llerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer, according to a new study published online October 9 in the Journal of the National Cancer Institute.
OPKO Health, Inc. today announced the acquisition of an exclusive license from Arctic Partners Ab Oy for two biomarkers in the kallikrein family which, used together with prostate specific antigen (PSA), can reduce the need for prostate biopsies by over 50%.
Deadly bacteria may be evolving antibiotic resistance by mimicking human proteins, according to a new study by the Translational Genomics Research Institute (TGen).
A fast-acting compound that appears to improve cognitive function impairments in mice similar to those found in patients with progressive Alzheimer's disease has been identified by scientists at Wake Forest University School of Medicine and the Vanderbilt University Medical Center Program in Drug Discovery.
› Verified 3 days ago
| Entity Name | Mary Hitchcock Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
Women with increased levels of M-llerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer, according to a new study published online October 9 in the Journal of the National Cancer Institute.
OPKO Health, Inc. today announced the acquisition of an exclusive license from Arctic Partners Ab Oy for two biomarkers in the kallikrein family which, used together with prostate specific antigen (PSA), can reduce the need for prostate biopsies by over 50%.
Deadly bacteria may be evolving antibiotic resistance by mimicking human proteins, according to a new study by the Translational Genomics Research Institute (TGen).
A fast-acting compound that appears to improve cognitive function impairments in mice similar to those found in patients with progressive Alzheimer's disease has been identified by scientists at Wake Forest University School of Medicine and the Vanderbilt University Medical Center Program in Drug Discovery.
› Verified 3 days ago
| Entity Name | The New London Hospital Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831200583 PECOS PAC ID: 5294643623 Enrollment ID: O20040713000500 |
News Archive
Women with increased levels of M-llerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer, according to a new study published online October 9 in the Journal of the National Cancer Institute.
OPKO Health, Inc. today announced the acquisition of an exclusive license from Arctic Partners Ab Oy for two biomarkers in the kallikrein family which, used together with prostate specific antigen (PSA), can reduce the need for prostate biopsies by over 50%.
Deadly bacteria may be evolving antibiotic resistance by mimicking human proteins, according to a new study by the Translational Genomics Research Institute (TGen).
A fast-acting compound that appears to improve cognitive function impairments in mice similar to those found in patients with progressive Alzheimer's disease has been identified by scientists at Wake Forest University School of Medicine and the Vanderbilt University Medical Center Program in Drug Discovery.
› Verified 3 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
Women with increased levels of M-llerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer, according to a new study published online October 9 in the Journal of the National Cancer Institute.
OPKO Health, Inc. today announced the acquisition of an exclusive license from Arctic Partners Ab Oy for two biomarkers in the kallikrein family which, used together with prostate specific antigen (PSA), can reduce the need for prostate biopsies by over 50%.
Deadly bacteria may be evolving antibiotic resistance by mimicking human proteins, according to a new study by the Translational Genomics Research Institute (TGen).
A fast-acting compound that appears to improve cognitive function impairments in mice similar to those found in patients with progressive Alzheimer's disease has been identified by scientists at Wake Forest University School of Medicine and the Vanderbilt University Medical Center Program in Drug Discovery.
› Verified 3 days ago
| Entity Name | Alice Peck Day Memorial Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1003803495 PECOS PAC ID: 6103737531 Enrollment ID: O20061104000184 |
News Archive
Women with increased levels of M-llerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer, according to a new study published online October 9 in the Journal of the National Cancer Institute.
OPKO Health, Inc. today announced the acquisition of an exclusive license from Arctic Partners Ab Oy for two biomarkers in the kallikrein family which, used together with prostate specific antigen (PSA), can reduce the need for prostate biopsies by over 50%.
Deadly bacteria may be evolving antibiotic resistance by mimicking human proteins, according to a new study by the Translational Genomics Research Institute (TGen).
A fast-acting compound that appears to improve cognitive function impairments in mice similar to those found in patients with progressive Alzheimer's disease has been identified by scientists at Wake Forest University School of Medicine and the Vanderbilt University Medical Center Program in Drug Discovery.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Evadne G Marcolini, MD 1 Medical Center Dr, Lebanon, NH 03756-0001 Ph: (203) 432-0076 | Dr Evadne G Marcolini, MD 1 Medical Center Dr, Lebanon, NH 03756 Ph: (603) 650-7254 |
News Archive
Women with increased levels of M-llerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer, according to a new study published online October 9 in the Journal of the National Cancer Institute.
OPKO Health, Inc. today announced the acquisition of an exclusive license from Arctic Partners Ab Oy for two biomarkers in the kallikrein family which, used together with prostate specific antigen (PSA), can reduce the need for prostate biopsies by over 50%.
Deadly bacteria may be evolving antibiotic resistance by mimicking human proteins, according to a new study by the Translational Genomics Research Institute (TGen).
A fast-acting compound that appears to improve cognitive function impairments in mice similar to those found in patients with progressive Alzheimer's disease has been identified by scientists at Wake Forest University School of Medicine and the Vanderbilt University Medical Center Program in Drug Discovery.
› Verified 3 days ago
Dr. Cecily Malise Reynolds, M.D., M.S. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Department Of Emergency Medicine, Lebanon, NH 03756 Phone: 603-650-7254 | |
Katherine Little, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dept. Of Emer. Med., Lebanon, NH 03756 Phone: 603-650-7254 | |
Douglas A Deaett, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 125 Mascoma St, Lebanon, NH 03766 Phone: 603-448-3121 Fax: 603-448-7462 | |
Dr. Patricia L Lanter, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dhmc - Dept Of Emergency Medicine, Lebanon, NH 03756 Phone: 603-650-7254 | |
Thomas W Trimarco, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Dhmc - Emergency Medicine, Lebanon, NH 03756 Phone: 603-650-7000 Fax: 603-650-4516 | |
Nancy Philips, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Drive, Dartmouth Hithcock Medical Center, Lebanon, NH 03756 Phone: 603-650-7254 | |
Jon Jordan Gray, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7254 |